前收市價 | 550.13 |
開市 | 548.81 |
買盤 | 550.21 x 900 |
賣出價 | 550.45 x 900 |
今日波幅 | 547.63 - 555.49 |
52 週波幅 | 304.88 - 601.84 |
成交量 | |
平均成交量 | 2,877,822 |
市值 | 522.625B |
Beta 值 (5 年,每月) | 0.32 |
市盈率 (最近 12 個月) | 76.68 |
每股盈利 (最近 12 個月) | 7.18 |
業績公佈日 | 2023年11月02日 |
遠期股息及收益率 | 4.52 (0.79%) |
除息日 | 2023年8月14日 |
1 年預測目標價 | 569.28 |
Benzinga Elon Musk-Backed Brain Implant Firm Neuralink Starts Participant Enrollment In Brain Implant Human Trial For Paralysis Elon Musk's brain-computer interface company, Neuralink, has initiated recruiting its first test subjects for human trials aimed at assisting individuals with paralysis in controlling devices. Neuralink announced that it has obtained approval from an independent institutional review board and the initial hospital site, enabling the commencement of recruitment for its fi
In this article, we will take a look at the 16 best low risk investments in 2023. To see more such companies, go directly to 5 Best Low Risk Investments in 2023. Investors are still in a wait and see mode after the latest inflation and retail sales report which give mixed signals. Some analysts […]
In this article, we discuss the 12 best pharma ETFs. If you want to skip our discussion on the pharma industry, you can go directly to the 5 Best Pharma ETFs. As of 2023, Deloitte has valued the pharmaceutical, biotechnology, and medical technology industries at $2.83 trillion. A report on the Global Pharmaceuticals Outlook by […]